Idera Pharmaceuticals, Inc.
IDRA · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$23,360 | $98,091 | -$112,662 | -$56,515 |
| Dep. & Amort. | $15 | $22 | $61 | $120 |
| Deferred Tax | -$6,318 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $254 | $388 | -$1,118 | -$3,265 |
| Other Non-Cash | $2,726 | -$125,635 | $76,306 | $11,317 |
| Operating Cash Flow | -$24,495 | -$24,597 | -$33,772 | -$44,498 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$8 | -$11 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$12,178 | -$44,502 |
| Inv. Sales/Matur. | $0 | $4,500 | $10,499 | $42,100 |
| Other Inv. Act. | $5,482 | $0 | $0 | $11 |
| Investing Cash Flow | $5,482 | $4,500 | -$1,687 | -$2,402 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$15 | $152 | $28,758 | $15,370 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,488 | $19,413 | $28,669 | $15,488 |
| Financing Cash Flow | -$1,488 | $19,413 | $28,669 | $15,488 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$20,501 | -$684 | -$6,790 | -$31,412 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $32,545 | $33,229 | $40,019 | $71,431 |
| End Cash | $12,044 | $32,545 | $33,229 | $40,019 |
| Free Cash Flow | -$24,495 | -$24,597 | -$33,780 | -$44,509 |